HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Molecular mechanism of proinflammatory cytokine-mediated squamous metaplasia in human corneal epithelial cells.

AbstractPURPOSE:
The cornified envelope protein small proline-rich protein 1B (SPRR1B) is a biomarker for squamous metaplasia. Proinflammatory cytokines IL-1beta and IFN-gamma are potent inducers of ocular surface keratinization and SPRR1B expression. Here the molecular mechanisms controlling SPRR1B gene expression in response to IL-1beta and IFN-gamma are elucidated.
METHODS:
A 3-kb fragment of the SPRR1B gene 5'-flanking region was amplified from human chromosome 1, sequentially deleted, and cloned into a luciferase vector. Constructs were transiently transfected into human corneal epithelial cells, and activity was assessed in response to IL-1beta, IFN-gamma, or basal medium. Functional cis-elements responding to IL-1beta and IFN-gamma were characterized by site-directed mutagenesis and gel mobility shift assay. Effects of mitogen-activated protein kinases p38, ERK, and JNK were assessed using inhibitors and dominant-negative mutants. Results were validated by real-time RT-PCR.
RESULTS:
The first 620 bp of the SPRR1B 5'-flanking region regulated constitutive expression and increased promoter activity in response to IL-1beta and IFN-gamma. Corresponding cis-elements for IL-1beta and IFN-gamma were bound by cAMP response element binding protein (CREB) and zinc-finger E-box binding homeobox 1 (ZEB1), respectively. Inhibition of p38 abolished the stimulatory effects of IL-1beta and IFN-gamma on SPRR1B, whereas inhibition of JNK and ERK had no effect. Dominant-negative mutants targeting p38alpha and p38beta2 blocked cytokine-induced SPRR1B promoter activity and mRNA expression.
CONCLUSIONS:
SPRR1B is upregulated by the proinflammatory cytokines IL-1beta and IFN-gamma via p38 MAPK-mediated signaling pathways that lead to the activation of transcription factors CREB and ZEB1, respectively. These results identify key intracellular signaling intermediates involved in the pathogenesis of immune-mediated ocular surface squamous metaplasia.
AuthorsShimin Li, Marianne Gallup, Ying-Ting Chen, Nancy A McNamara
JournalInvestigative ophthalmology & visual science (Invest Ophthalmol Vis Sci) Vol. 51 Issue 5 Pg. 2466-75 (May 2010) ISSN: 1552-5783 [Electronic] United States
PMID20042643 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
Chemical References
  • Antigens, Polyomavirus Transforming
  • Biomarkers
  • Cornified Envelope Proline-Rich Proteins
  • Cyclic AMP Response Element-Binding Protein
  • Homeodomain Proteins
  • Interleukin-1beta
  • RNA, Messenger
  • Transcription Factors
  • ZEB1 protein, human
  • Zinc Finger E-box-Binding Homeobox 1
  • SPRR1B protein, human
  • Interferon-gamma
  • Extracellular Signal-Regulated MAP Kinases
  • p38 Mitogen-Activated Protein Kinases
  • MAP Kinase Kinase 4
Topics
  • Antigens, Polyomavirus Transforming
  • Biomarkers
  • Cell Culture Techniques
  • Cell Line, Transformed
  • Cornea (pathology)
  • Cornified Envelope Proline-Rich Proteins (genetics)
  • Cyclic AMP Response Element-Binding Protein (genetics, metabolism)
  • Electrophoretic Mobility Shift Assay
  • Epithelium, Corneal (drug effects, metabolism, pathology)
  • Extracellular Signal-Regulated MAP Kinases (metabolism)
  • Gene Expression Regulation (physiology)
  • Homeodomain Proteins (genetics, metabolism)
  • Humans
  • Interferon-gamma (pharmacology)
  • Interleukin-1beta (pharmacology)
  • MAP Kinase Kinase 4 (metabolism)
  • Metaplasia
  • Mutagenesis, Site-Directed
  • RNA, Messenger (metabolism)
  • Reverse Transcriptase Polymerase Chain Reaction
  • Transcription Factors (genetics, metabolism)
  • Transfection
  • Zinc Finger E-box-Binding Homeobox 1
  • p38 Mitogen-Activated Protein Kinases (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: